Gavin MacBeath - Jan 12, 2024 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role: Chief Executive Officer, Director
Signature: /s/ Gavin MacBeath
Stock symbol: TCRX
Transactions as of: Jan 12, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/11/2025, 05:52 PM
Previous filing: Jun 15, 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TCRX	Stock Option (Right to Buy)	Award	$0	+160K		$0.00	160K	Jan 12, 2024	Voting Common Stock	160K	$6.00	Direct	F1
transaction	TCRX	Stock Option (Right to Buy)	Award	$0	+800K		$0.00	800K	Jan 3, 2025	Voting Common Stock	800K	$3.07	Direct	F2

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 12, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.
F2	The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 3, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.